CPC Chronic Disease Management 2 — Questions and Answers

Question 1: A patient with COPD has a FEV1/FVC ratio of 0.62 and a post-bronchodilator FEV1 of 55% predicted. According to GOLD classification, this patient is classified as:

GOLD 1 — Mild
GOLD 2 — Moderate (Correct answer)
GOLD 3 — Severe
GOLD 4 — Very Severe

Correct answer: GOLD 2 — Moderate

GOLD classification by FEV1 (post-bronchodilator, FEV1/FVC <0.70): GOLD 1 ≥80%, GOLD 2 50–79%, GOLD 3 30–49%, GOLD 4 <30%. An FEV1 of 55% predicted falls within GOLD 2 (Moderate).

The GOLD (Global Initiative for Chronic Obstructive Lung Disease) classification system grades COPD severity by post-bronchodilator FEV1 as a percentage of predicted: GOLD 1 (≥80%), GOLD 2 (50–79%), GOLD 3 (30–49%), GOLD 4 (<30%). The FEV1/FVC ratio <0.70 confirms obstructive pattern. For community paramedicine purposes, GOLD grade informs inhaler regimen review (LAMA, LABA, ICS), exacerbation risk assessment, and appropriate activity limitations. GOLD also incorporates symptom burden (CAT score or mMRC dyspnea scale) and exacerbation history into overall ABCD assessment groups for treatment decisions.

Question 2: A community paramedic reviews a patient's inhaler technique during a home visit for COPD management. Which finding indicates INCORRECT metered-dose inhaler (MDI) technique?

Patient shakes the inhaler before use
Patient inhales quickly and forcefully rather than slowly and deeply (Correct answer)
Patient holds breath for 10 seconds after inhalation
Patient waits 1 minute between puffs

Correct answer: Patient inhales quickly and forcefully rather than slowly and deeply

Correct MDI technique requires a SLOW, deep inhalation coordinated with actuation — not a fast, forceful breath. Rapid inhalation causes most of the medication to deposit in the oropharynx rather than the lower airways.

Proper MDI technique: (1) shake the inhaler; (2) exhale fully; (3) place the mouthpiece 2 finger-widths in front of open mouth or seal lips around mouthpiece; (4) begin slow, deep inhalation and simultaneously actuate the inhaler; (5) continue slow inhalation for 3–5 seconds; (6) hold breath for 10 seconds; (7) exhale slowly; (8) wait 1 minute between puffs. A fast, forceful breath causes large particles to impact the oropharynx, reducing lung deposition from ~20% (correct) to <10% (incorrect). Community paramedics assess and correct inhaler technique at every COPD home visit — poor technique is among the most correctable causes of uncontrolled COPD.

Question 3: Which target HbA1c is recommended by the American Diabetes Association for most non-pregnant adults with type 2 diabetes?

<6.0%
<7.0% (Correct answer)
<8.0%
<9.0%

Correct answer: <7.0%

The ADA recommends an HbA1c target of <7.0% for most non-pregnant adults with type 2 diabetes, balancing glycemic control benefits against hypoglycemia risk. Less stringent targets (e.g., <8.0%) may be appropriate for elderly or high-risk patients.

ADA Standards of Medical Care in Diabetes recommends HbA1c <7.0% for most non-pregnant adults, corresponding to an estimated average glucose of ~154 mg/dL. A more stringent target (<6.5%) may be appropriate for selected patients without hypoglycemia risk. Less stringent targets (<8.0%) are acceptable for patients with: limited life expectancy, extensive comorbidities, long disease duration, history of severe hypoglycemia, advanced complications, or reduced access to care. Community paramedics assess HbA1c in context — applying individualized targets when reviewing diabetic patients' lab values and medication adherence during home visits.

Question 4: Which assessment finding in a heart failure patient indicates WORSENING fluid status requiring immediate escalation?

Weight gain of 0.5 lb over 3 days
Weight gain of 3 lbs in 24 hours with increased dyspnea (Correct answer)
Mild ankle edema without dyspnea
BNP of 250 pg/mL at a stable baseline

Correct answer: Weight gain of 3 lbs in 24 hours with increased dyspnea

A rapid weight gain of 3 lbs or more within 24 hours combined with worsening dyspnea is a cardinal sign of acute decompensated heart failure requiring urgent escalation to the patient's cardiologist or emergency services.

Heart failure self-monitoring protocols universally use daily weight as the most sensitive early warning sign of fluid retention. The 'action weight' threshold is typically a 3-lb gain in 24 hours or 5-lb gain in 7 days. Combined with worsening dyspnea, orthopnea, paroxysmal nocturnal dyspnea, or peripheral edema, rapid weight gain indicates acute decompensated heart failure requiring urgent evaluation and possible diuretic adjustment. Community paramedics track weight trends during home visits, educate patients on daily self-weighing protocols, and have clear escalation pathways per standing orders (e.g., patient-directed furosemide dose adjustment or direct cardiologist contact).

Question 5: For a patient with chronic kidney disease (CKD) Stage 3b, which dietary modification is MOST important to slow disease progression?

High-protein diet to prevent muscle wasting
Low-protein diet (0.6–0.8 g/kg/day) to reduce hyperfiltration and uremic solute load (Correct answer)
Elimination of all carbohydrates
Unrestricted sodium intake

Correct answer: Low-protein diet (0.6–0.8 g/kg/day) to reduce hyperfiltration and uremic solute load

Dietary protein restriction (0.6–0.8 g/kg/day) reduces the glomerular filtration burden (hyperfiltration) and decreases production of uremic toxins, slowing progression of CKD in stages 3–4.

CKD Stage 3b is defined by eGFR 30–44 mL/min/1.73m². KDIGO guidelines recommend protein intake of 0.6–0.8 g/kg/day for CKD patients not on dialysis, as dietary protein generates urea and other nitrogenous waste products that drive uremic progression. Hyperfiltration from excessive protein intake accelerates nephron damage. Additional key dietary modifications in CKD: sodium restriction (<2 g/day for HTN/edema), potassium restriction if hyperkalemic, phosphorus restriction. Community paramedics in CKD programs review dietary logs, reinforce nephrology dietary guidance, and monitor laboratory trends (eGFR, BUN, creatinine, potassium, phosphorus).

Question 6: A patient with asthma reports using their rescue inhaler (albuterol) more than 2 days per week. This symptom pattern indicates asthma control classified as:

Well-controlled
Not well-controlled (Correct answer)
Very poorly controlled
In remission

Correct answer: Not well-controlled

Per NAEPP/GINA guidelines, rescue inhaler use >2 days per week (but not daily) indicates 'not well-controlled' asthma, warranting step-up in controller therapy and reassessment of triggers and adherence.

NAEPP Step Therapy classifies asthma control as: Well-controlled (symptoms ≤2 days/week, rescue inhaler ≤2 days/week, no nighttime awakenings, no activity limitation), Not well-controlled (symptoms or rescue inhaler use >2 days/week but not daily, some nighttime awakenings), or Very poorly controlled (symptoms throughout the day, rescue inhaler use multiple times per day). Use of albuterol >2 days/week signals inadequate baseline control, usually indicating need for an inhaled corticosteroid (ICS) or step-up in existing controller regimen. Community paramedics identify overuse of SABA inhalers as a key quality indicator during home visits.

CPC Chronic Disease Management 2

A patient with COPD has a FEV1/FVC ratio of 0.62 and a post-bronchodilator FEV1 of 55% predicted.
According to GOLD classification, this patient is classified as: